Viruses detected among sporadic cases of parotitis, United States, 2009-2011

Journal of Infectious Diseases

Volumn 208, Issue 12, 2013, Pages 1979-1986

  Barskey, Albert E ^a,b,c   Juieng, Phalasy ^b   Whitaker, Brett L ^a   Erdman, Dean D ^a   Oberste, M Steven ^a   Chern, Shur Wern Wang ^a   Schmid, D Scott ^a   Radford, Kay W ^a   McNall, Rebecca J ^a   Rota, Paul A ^a   Hickman, Carole J ^a   Bellini, William J ^a   Wallace, Gregory S ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Diagnostics; Mumps; Parotitis

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY; VIRUS DNA; VIRUS RNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY DETECTION; ARTICLE; BOCAVIRUS; CHILD; CONTROLLED STUDY; ENTEROVIRUS; ENZYME IMMUNOASSAY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN HERPESVIRUS 6; INFANT; MAJOR CLINICAL STUDY; MALE; MUMPS VIRUS; PARAINFLUENZA VIRUS 2; PARAINFLUENZA VIRUS 3; PARECHOVIRUS; PAROTITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEASONAL VARIATION; SEROLOGY; SEX DIFFERENCE; THROAT CULTURE; UNITED STATES; VIRUS DETECTION; VIRUS LOAD; VIRUS TITRATION; BLOOD; DIAGNOSIS; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; MUMPS; PRESCHOOL CHILD; SEASON; VIROLOGY; VIRUS;

DIAGNOSTICS; MUMPS; PAROTITIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; HERPESVIRUS 4, HUMAN; HERPESVIRUS 6, HUMAN; HUMANS; INFANT; MALE; MIDDLE AGED; MUMPS VIRUS; PAROTITIS; RNA, VIRAL; SEASONS; UNITED STATES; VIRUSES;

EID: 84897121867     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jit408     Document Type: Article

References (47)

1. Plotkin SA, Rubin SA. Mumps vaccine. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 5th ed. Philadelphia, PA: Elsevier, 2008: 435-65.
2. Council of State and Territorial Epidemiologists. CSTE position statement 09-ID-50. http://c.mcdn.com/sites/www.cste.org/resource/resmgr/PS/09-ID-50.pdf. Accessed 4 February 2013.
3. Yoshida N, Fujino M, Miyata A, et al. Mumps virus reinfection is not a rare event confirmed by reverse transcription loop-mediated isothermal amplification. J Med Virol 2008; 80:517-23.
4. Briss PA, Fehrs LJ, Parker RA, et al. Sustained transmission of mumps in a highly vaccinated population: Assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis 1994; 169:77-82.
5. Narita M, Matsuzono Y, Takekoshi Y, et al. Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G. Clin Diagn Lab Immunol 1998; 5:799-803.
6. Rota JS, Turner JC, Yost-Daljev MK, et al. Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006. J Med Virol 2009; 81:1819-25.
7. Barskey AE, Glasser JW, LeBaron CW. Mumps resurgences in the United States: A historical perspective on unexpected elements. Vaccine 2009; 27:6186-95.
8. Council of State and Territorial Epidemiologists. State reportable conditions website. http//www.cste.org/?page=StateReportable8thhSearchTerms= state+and+reportable+and+conditions. Accessed 4 February 2013.
9. Dayan GH, Quinlisk MP, Parker AA, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008; 358:1580-9.
10. Rubin S, Carbone KM. Mumps (chapter 194). In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, eds. Harrison's principles of internal medicine. 18th ed. New York: McGraw-Hill, 2012. http://www.accessmedicine.com/ content.aspx?aID=9124557. Accessed 7 February 2013.
11. Davidkin I, Jokinen S, Paananen A, Leinikki P, Peltola H. Etiology of mumps-like illnesses in children and adolescents vaccinated for measles, mumps, and rubella. J Infect Dis 2005; 191:719-23.
12. McQuone SJ. Acute viral and bacterial infections of the salivary glands. Otolaryngol Clin North Am 1999; 32:793-811.
13. Brill SJ, Gilfillan RF. Acute parotitis associated with influenza type A: A report of twelve cases. N Engl J Med 1977; 296:1391-2.
14. Akin M, Carman KB, Karaturk AH, Ceran O. Mumps-like syndrome owing to parvovirus B19: A brief report. Ann Trop Paediatr 2002; 22:57-8.
15. Rota JS, Rosen JB, Doll MK, et al Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York City in 2009. Clin Vaccine Immunol 2013; 20:391-6.
16. Stamey FR, Patel MM, Holloway BP, Pellett PE. Quantitative, fluorogenic probe PCR assay for detection of human herpesvirus 8 DNA in clinical specimens. J Clin Microbiol 2001; 39:3537-40.
17. Oberste MS, Pallansch MA. Enterovirus molecular detection and typing. Rev Med Microbiol 2005; 16:163-71.
18. Nix WA, Maher K, Johansson ES, et al. Detection of all known parecho- viruses by real-time PCR. J Clin Microbiol 2008; 46:2519-24.
19. Heim A, Ebnet C, Harste G, Pring-Akerblom P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol 2003; 70:228-39.
20. Morgan OW, Chittaganpitch M, Clague B, et al. Hospitalization due to human parainfluenza virus-associated lower respiratory tract illness in rural Thailand. Influenza Other Respi Viruses 2013; 7:280-5.
21. Lu X, Chittaganpitch M, Olsen SJ, et al. Real-time PCR assays for detection of bocavirus in human specimens. J Clin Microbiol 2006; 44:3231-5.
22. Saarinen R, Kolho KL, Lauhio A, et al. Herpes viruses lack association with acute parotitis in children. Pediatr Infect Dis J 2011; 30:1120.
23. Hatchette TF, Mahony JB, Chong S, LeBlanc JJ. Difficulty with mumps diagnosis: what is the contribution of mumps mimickers? J Clin Virol 2009;46:381-3.
24. Sakata H, Tsurudome M, Hishiyama M, Ito Y, Sugiura A. Enzyme- linked immunosorbent assay for mumps IgM antibody: comparison of IgM capture and indirect IgM assay. J Virol Methods 1985; 12:303-11.
25. Cunningham C, Faherty C, Cormican M, Murphy AW. Importance of clinical features in diagnosis of mumps during a community outbreak. Ir Med J 2006; 99:171-3.
26. Krause CH, Molyneaux PJ, Ho-Yen DO, McIntyre P, Carman WF, Templeton KE. Comparison of mumps-IgM ELISAs in acute infection. J Clin Virol 2007; 38:153-6.
27. Meurman O, Hanninen P, Krishna RV, Ziegler T. Determination of IgG- and IgM-class antibodies to mumps virus by solid-phase enzyme immunoassay. J Virol Methods 1982; 4:249-56.
28. Tuokko H. Comparison of nonspecific reactivity in indirect and reverse immunoassays for measles and mumps immunoglobulin M antibodies. J Clin Microbiol 1984; 20:972-6.
29. Rosén A, Gergely P, Jondal M, Klein G, Britton S. Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature 1977; 267:52-4.
30. Morgan-Capner P, Tedder RS, Mace JE. Rubella-specific IgM reactivity in sera from cases of infectious mononucleosis. J Hyg (Lond) 1983; 90:407-13.
31. Julkunen I. Serological diagnosis of parainfluenza virus infections by enzyme immunoassay with special emphasis on purity of viral antigens. J Med Virol 1984; 14:177-87.
32. Frankovd V, Holubovd J, Grubhoffer L, Kasovd V. Contribution to laboratory diagnosis of mumps and parainfluenza. Acta Virol 1988; 32: 503-14.
33. Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, Lebaron CW. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students-Iowa, 2006. Vaccine 2008; 26:3601-7.
34. Cohen C, White JM, Savage EJ, et al Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 2007; 13:12-7.
35. Harling R, White JM, Ramsay ME, MacSween KF, van den Bosch C. The effectiveness of the mumps component of the MMR vaccine: A case control study. Vaccine 2005; 23:4070-4.
36. Deeks SL, Lim GH, Simpson MA, et al. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. CMAJ 2011;183:1014-20.
37. Fry AM, Curns AT, Harbour K, Hutwagner L, Holman RC, Anderson LJ. Seasonal trends of human parainfluenza viral infections: United States, 1990-2004. Clin Infect Dis 2006; 43:1016-22.
38. Kesebir D, Vazquez M, Weibel C, et al. Human bocavirus infection in young children in the United States: molecular epidemiological profile and clinical characteristics of a newly emerging respiratory virus. J Infect Dis 2006; 194:1276-82.
39. Human herpesvirus 6 (including roseola) and 7. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book: 2012 report of the committee on infectious diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2012:414-6.
40. Epstein-Barr virus infections. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book: 2012 report of the committee on infectious diseases. 29th ed. Elk Grove Village, IL American Academy of Pediatrics, 2012:318-21.
41. Adenovirus infections. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book: 2012 report of the committee on infectious diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2012:220-2.
42. Davidkin I, Kontio M, Paunio M, Peltola H. MMR vaccination and disease elimination: The Finnish experience. Expert Rev Vaccines 2010; 9:1045-53.
43. World Health Organization. Immunization surveillance, assessment and monitoring, http://www.who.int/entity/immunization-monitoring/data/year-vaccine- introductionjds. Accessed 10 June 2013.
44. Greenland K, Whelan J, Fanoy E, et al. Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, Vaccine 2012; 30:4676-80.
45. Roberts C, Porter-Jones G, Crocker J, Hart J. Mumps outbreak on the island of Anglesey, North Wales, December 2008-January 2009. Euro Surveill 2009; 14. p:19109.
46. Bangor-Jones RD, Dowse GK, Giele CM, van Buynder PG, Hodge MM, Whitty MM. A prolonged mumps outbreak among highly vaccinated Aboriginal people in the Kimberley region of Western Australia. Med J Aust 2009; 191:398-401.
47. Centers for Disease Control and Prevention. National and state vaccination coverage among adolescents aged 13-17 years-United States, MMWR Morb Mortal Wkly Rep 2012; 61:671-7.